Application 213561
- Type
- ANDA
- Sponsor
- HIKMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATROPINE SULFATE | ATROPINE SULFATE | SOLUTION;INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAOSSEOUS, ENDOTRACHEAL | 8MG/20ML (0.4MG/ML) | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0404-9990 | ATROPINE SULFATE | atropine sulfate injection | Henry Schein, Inc. | ANDA | Current |
| 0641-6251 | Atropine Sulfate | Atropine Sulfate | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 51662-1619 | ATROPINE SULFATE | ATROPINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |
| 51662-1619 | ATROPINE SULFATE | ATROPINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | ANDA | Current |